NA Proactive news snapshot: Phunware, AgraFlora Organics, eWellness, Helix BioPharma UPDATE ...

Phunware Inc (NASDAQ:PHUN) has deployed its multiscreen-as-a-service platform to support a custom mobile application for its latest customer, one the nation’s largest health systems. Because of the scope of its new customer, Phunware’s MaaS platform will provide location-based services (LBS) to more than 22 million square feet across 30 facilities. Helping patients navigate these facilities is crucial to addressing the $150 billion lost every year in the US due to missed healthcare appointments, the company said, citing data from the Pittsburgh Post-Gazette. AgraFlora Organics International Inc (CSE:AGRA) (OTCMKTS:AGFAF) has closed the acquisition of Candian cannabis company Sanna Health Corp, originally announced back in December. Sanna Health, based in Toronto, operates a 16-acre, 27,000 sq ft Health Canada licensed cultivation and processing space. The company holds an option to expand its production to 89,000 sq ft in addition to more commercial-industrial space. AgraFlora acquired all of the issued and outstanding shares of Sanna in exchange for 76,666,666 shares. eWellness Healthcare Corporation (OTCMKTS:EWLL), a telemedicine provider, has seen a significant swell in treatments on its digital PHIZIO telehealth platform as patients take steps to reduce their exposure to Covid-19 (coronavirus). The uptick began Thursday, as major sport leagues have suspended seasons, Broadway has gone dark in New York and people are being encouraged to avoid large crowds. "We are advising our partners that they should implement a Plan of Care option for the transference of patients from in-clinic treatment plans to virtual care treatment plans in the face of the Coronavirus continuing to spread globally,” CEO Darwin Fogt said.  Helix BioPharma Corp (TSE:HBP) (OCTMKTS:HBPCF), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, has closed a private placement financing of 5,042,016 units at a price of $1.0332 apiece. Also the company reported the concurrent disposition of 1,708,023 shares of its Polish subsidiary, Helix Immuno-Oncology SA (HIO), to a third-party purchaser, representing an 15.5% equity stake in HIO. Together with the units and purchased securities aggregate gross proceeds come to CAD $6 million, or C$1.19 per purchased security. Rach Unit is comprised of one common share and one common share purchase warrant, which will entitle the holder to purchase one common share at $1.67 and have an expiry of five years from the date of issuance. TIMIA Capital Corporation (CVE:TCA) (OTCMKTS:TIMCF) said that its board has approved the grant of 605,000 stock options to its staff and officers which are exercisable as shares at a price of $0.20 per share in line with Toronto Stock Exchange policy 4.4. Out of the 605,000 options, officers received 180,000 with the staff receiving the remainder. The options have a five-year term and will expire on March 11, 2025. Timia Capital is a revenue financing company that provides investment capital to Canadian tech firms in exchange for a royalty on revenue. Gatling Exploration Inc (CVE:GTR) (OTCMKTS:GATGF) received a repeated 'Buy' from Jay Taylor in the February 17 edition of Gold, Energy & Tech Stocks. Gatling is well on its way to establishing a multimillion-ounce gold deposit, reckons Mr  Taylor. He said buy for the first time on November 12 last year at 45 cents. A $1,000 investment then is now worth $1,044. Given Gatling's market cap of just C$27 million, the market is paying very little attention to its drilling efforts, but Taylor believes that simply underscores this "excellent opportunity". Co-Diagnostics Inc’s (NASDAQ:CODX) COVID-19 test will be exclusively distributed in Ecuador by PreCheck Health Services Inc (OTCMKTS:HLTY). In a statement Friday, PreCheck said it has ordered an initial 30,000 COVID-19 tests and will be registering the product in Ecuador, which has a population of 16 million. The company’s Latin American division will handle distribution.  “It’s been a productive month for PreCheck,” said PreCheck CEO Justin Anderson, noting that his Texas company had also entered into an exclusive agreement with Co-Diagnostics to distribute its COVID-19 tests as well as other infectious disease kits in Russia.  Biotech CytoDyn Inc (OTCMKTS:CYDY), which is developing leronlimab (PRO 140) to treat different types of diseases, has named experienced clinician Dr Jacob P. Lalezari as its interim chief medical officer. Lalezari is currently leading the company's immediate preparations to carry out a coronavirus (COVID-19) clinical trial. Tidal Royalty Corp (CSE:RLTY.U) (OTCMKTS:TDRYF) has amended its business combination agreement with MichiCann Medical Inc, signing a restated deal to acquire the firm’s issued and outstanding shares on a 2:1 basis. The entities do business together under the name Red White & Bloom following an original deal from May 2019. The share considerations will now consist of one common share and one Series 2 convertible preferred share. The Series 2 shares issued to MichiCann will carry voting rights. Nano One Materials Inc (CVE:NNO) said the TSX Venture Exchange has accepted for filing documentation with respect to its non-brokered private placement, first announced on January 30, 2020, which will see the issue of 9,565,000 shares at a purchase price of $1.15 each, together with 4,782,500 share purchase warrants at an exercise price of $1.60 each for a three-year period, with 203 placees.